John Clayton Taylor serves as Executive at IDERA PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, John Clayton Taylor has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 17, 2023 involved exercising options for 1,341,764 shares valued at $0.
John Clayton Taylor currently holds 1,469,482 shares of IDERA PHARMACEUTICALS, INC. (IDRA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Clayton Taylor has been a net neutral trader of IDRA stock. They have purchased $0 and sold $0 worth of shares.
John Clayton Taylor's most recent insider trade was on Jan 17, 2023, when they sold 1,341,764 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |